Macrogenics Inc (MGNX): Revenue
$149.50M
Year ended 2025-12-31
-0.5%
3-year compound annual growth
+7.3%
5-year compound annual growth
+4.0%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $149.50M | -0.3% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $149.96M | +155.3% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $58.75M | -61.3% | 2026-03-09, From 2023-01-01 |
| 2022-12-31 | $151.94M | +96.2% | 2025-03-20, From 2022-01-01 |
| 2021-12-31 | $77.45M | -26.2% | 2024-03-07, From 2021-01-01 |
| 2020-12-31 | $104.88M | +63.4% | 2023-03-15, From 2020-01-01 |
| 2019-12-31 | $64.19M | +6.8% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $60.12M | -61.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $157.74M | +71.7% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $91.88M | -8.9% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $100.85M | +111.0% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $47.80M | -17.6% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $58.03M | -9.1% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $63.83M | +11.6% | 2015-03-03, From 2012-01-01 |
| 2011-12-31 | $57.21M | n/a | 2014-03-20, From 2011-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Macrogenics Inc (MGNX) | 2025-12-31 | $149.50M | -0.3% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $148.87M | +77.1% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $146.07M | +0.6% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $154.90M | +7.4% |
| Liquidia Corp (LQDA) | 2025-12-31 | $158.32M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $172.35M | +627.8% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $128.87M | +0.5% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $175.11M | +216.9% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $176.18M | +12.4% |
Compare MGNX, ELTP, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗